{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-021889","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2022-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.496525+00:00","generated_at":"2026-06-22T09:49:32.553704+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"agilon health Q3 revenue +52% to $695M, medical margin up 74%, raises FY2022 guidance","bullets":["Revenue $695M (+52% YoY); total platform members 356,000 with 266,600 MA members (+45%).","Medical margin $76M (+74% YoY); margin rate 10.9% vs 9.5% prior year.","Net loss $31M vs $36M; Adjusted EBITDA -$5M vs -$14M (nine-month Adj. EBITDA positive $15M).","FY2022 guidance raised: revenue $2.674-2.683B, medical margin $300-309M, Adj. EBITDA $2-7M.","Cash and marketable securities $959M, total debt $45M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-021889","json":"https://secwatch.observer/filing/0000950170-22-021889.json","markdown":"https://secwatch.observer/filing/0000950170-22-021889.md","text":"https://secwatch.observer/filing/0000950170-22-021889.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000095017022021889/0000950170-22-021889-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000095017022021889/agl-20221103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T09:49:32.553704+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ed829016a29041b2dc9b907ebd41b90591cc4223","claim":"agilon health, inc. reported financial results for the third quarter ended September 30, 2022.","evidence_excerpt":"On November 3, 2022, agilon health, inc., a Delaware corporation, issued a press release setting forth its financial results for the three and nine months ended September 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831097/000095017022021889/0000950170-22-021889-index.htm","confidence":0.8,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}